PT  - JOURNAL ARTICLE
AU  - Carlton, Lauren H.
AU  - Chen, Tiffany
AU  - Whitcombe, Alana L.
AU  - McGregor, Reuben
AU  - Scheurich, Greg
AU  - Sheen, Campbell R.
AU  - Dickson, James M.
AU  - Bullen, Chris
AU  - Chiang, Annie
AU  - Exeter, Daniel J.
AU  - Paynter, Janine
AU  - Baker, Michael G.
AU  - Charlewood, Richard
AU  - Moreland, Nicole J.
TI  - Charting Elimination in the Pandemic: A SARS-CoV-2 Serosurvey of Blood Donors in New Zealand
AID  - 10.1101/2021.04.12.21255282
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.12.21255282
4099  - http://medrxiv.org/content/early/2021/04/19/2021.04.12.21255282.short
4100  - http://medrxiv.org/content/early/2021/04/19/2021.04.12.21255282.full
AB  - A large-scale SARS-CoV-2 serosurvey of New Zealand blood donors (n=9806) was conducted at the end of 2020. Seroprevalence, after adjusting for test sensitivity and specificity, was very low (0.1%). This finding is consistent with limited community transmission and provides robust evidence to support New Zealand’ s successful elimination strategy for COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the School of Medicine Foundation (University of Auckland), and the COVID-19 Innovation Acceleration Fund (Ministry of Business, Innovation and Employment).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Health and Disability Ethics Committees New ZealandAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available on request from the corresponding author, NJM, upon reasonable request.